Senate bill S1096-119

Judiciary Committee

A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products.

• Last activity on Mar 24, 2025

• Introduced Mar 24, 2025

• By Sen. Klobuchar, Amy [D-MN]

Support this bill Share this bill
UnPac
12:45
Hi, welcome to UnPac!! ask me anything about UnPac and I'll try to help out. 😄